Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05273268 · ClinicalTrials.gov registry record · NA
ZOE METHOD Study: Comparing Personalized vs. Generalized Nutrition Guidelines
A NA study, sponsored by Zoe Global Limited.
- Completed
- Registry status
- NA
- Development phase
- 347
- Enrollment target
NCT05273268: Completed NA study, sponsored by Zoe Global Limited.
NCT05273268 is a NA study that has completed, run by Zoe Global Limited. The registered enrollment target is 347 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05273268, a NA study, has completed, sponsored by Zoe Global Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 347 participants
- Enrollment target
Study Summary
The ZOE Method Study will test the efficacy of personalized nutritional advice, delivered on an individual level through a digital device app; integrating dietary, lifestyle, physiological and metagenomic data, in improving certain cardiometabolic disease risk factors, compared to generalized nutrition advice (control).
Primary Outcome
Fasted measurement of triglycerides and LDL-cholesterol (mmol/L) by venous blood draw.
Interventions
- OTHER Personalized nutrition
- OTHER Generalized nutrition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2023-09-08 |
| Phase | NA |
What the finished NCT05273268 record still lists
NCT05273268 is an interventional study that assigns participants to a tested intervention. The registered 347 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Personalized nutrition is the first listed.
NCT05273268 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05273268 about?
NCT05273268 is a clinical study titled "ZOE METHOD Study: Comparing Personalized vs. Generalized Nutrition Guidelines". The ZOE Method Study will test the efficacy of personalized nutritional advice, delivered on an individual level through a digital device app; integrating dietary, lifestyle, physiological and metagenomic data, in improving certain cardiometabolic disease risk factors, compared to generalized nutrit...
What is the current status of trial NCT05273268?
This trial is currently completed. It is a NA study. The enrollment target is 347 participants. The study started on 2022-04-04. Estimated completion is 2023-09-08.
What interventions are being tested in trial NCT05273268?
The interventions under investigation include: Personalized nutrition (OTHER), Generalized nutrition (OTHER).
Who is sponsoring clinical trial NCT05273268?
This trial is sponsored by Zoe Global Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05273268's enrollment target sits among peer trials
347 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- NCT04877522 · 347 participants · Phase 4
Asciminib Roll-over Study
- NCT05834660 · 347 participants · NA
SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools
- NCT06963827 · 347 participants · Phase 3
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI